TAMIGA: A PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF CONTINUOUS BEVACIZUMAB THROUGH MULTIPLE LINES OF TREATMENT FOR GLIOBLASTOMA

Alba Brandes; Miquel Gil Gil; Frank Saran; Antoine F. Carpentier; Anna Nowak; Warren Mason; Francois Dubois; Gaetano Finocchiaro; George Fountzilas; Vittorina Zagonel; Dana M. Cernea; Olivier Chinot; Martina Makrutzki; Chiedzo Mpofu; Hans-Joerg Urban; Josef Pichler

TAMIGA: A PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF CONTINUOUS BEVACIZUMAB THROUGH MULTIPLE LINES OF TREATMENT FOR GLIOBLASTOMA

Alba Brandes, Miquel Gil Gil, Frank Saran, Antoine F. Carpentier, Anna Nowak, Warren Mason, Francois Dubois, Gaetano Finocchiaro, George Fountzilas, Vittorina Zagonel, Dana M. Cernea, Olivier Chinot, Martina Makrutzki, Chiedzo Mpofu, Hans-Joerg Urban, Josef Pichler

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

1 Citation (Web of Science)

Original language	English
Pages (from-to)	17-18
Number of pages	2
Journal	Neuro-Oncology
Volume	19
Publication status	Published - Nov 2017
Externally published	Yes
Event	22nd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology - San Francisco, United States Duration: 16 Nov 2017 → 19 Nov 2017

Cite this

Brandes, A., Gil Gil, M., Saran, F., Carpentier, A. F., Nowak, A., Mason, W., Dubois, F., Finocchiaro, G., Fountzilas, G., Zagonel, V., Cernea, D. M., Chinot, O., Makrutzki, M., Mpofu, C., Urban, H.-J., & Pichler, J. (2017). TAMIGA: A PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF CONTINUOUS BEVACIZUMAB THROUGH MULTIPLE LINES OF TREATMENT FOR GLIOBLASTOMA. Neuro-Oncology, 19, 17-18.

@article{537ee4662fe94abebfe80c2867111cff,

title = "TAMIGA: A PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF CONTINUOUS BEVACIZUMAB THROUGH MULTIPLE LINES OF TREATMENT FOR GLIOBLASTOMA",

author = "Alba Brandes and {Gil Gil}, Miquel and Frank Saran and Carpentier, {Antoine F.} and Anna Nowak and Warren Mason and Francois Dubois and Gaetano Finocchiaro and George Fountzilas and Vittorina Zagonel and Cernea, {Dana M.} and Olivier Chinot and Martina Makrutzki and Chiedzo Mpofu and Hans-Joerg Urban and Josef Pichler",

year = "2017",

month = nov,

language = "English",

volume = "19",

pages = "17--18",

journal = "Neuro-Oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

note = "22nd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology ; Conference date: 16-11-2017 Through 19-11-2017",

}

Brandes, A, Gil Gil, M, Saran, F, Carpentier, AF, Nowak, A, Mason, W, Dubois, F, Finocchiaro, G, Fountzilas, G, Zagonel, V, Cernea, DM, Chinot, O, Makrutzki, M, Mpofu, C, Urban, H-J & Pichler, J 2017, 'TAMIGA: A PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF CONTINUOUS BEVACIZUMAB THROUGH MULTIPLE LINES OF TREATMENT FOR GLIOBLASTOMA', Neuro-Oncology, vol. 19, pp. 17-18.

TY - JOUR

T1 - TAMIGA

T2 - 22nd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology

AU - Brandes, Alba

AU - Gil Gil, Miquel

AU - Saran, Frank

AU - Carpentier, Antoine F.

AU - Nowak, Anna

AU - Mason, Warren

AU - Dubois, Francois

AU - Finocchiaro, Gaetano

AU - Fountzilas, George

AU - Zagonel, Vittorina

AU - Cernea, Dana M.

AU - Chinot, Olivier

AU - Makrutzki, Martina

AU - Mpofu, Chiedzo

AU - Urban, Hans-Joerg

AU - Pichler, Josef

PY - 2017/11

Y1 - 2017/11

M3 - Abstract/Meeting Abstract

SN - 1522-8517

VL - 19

SP - 17

EP - 18

JO - Neuro-Oncology

JF - Neuro-Oncology

Y2 - 16 November 2017 through 19 November 2017

ER -